|
1
|
Bhoge A, Khandeparkar SGS, Joshi AR,
Gogate B, Kulkarni MM and Bhayekar P: Immunohistochemical study of
MUC1 and MUC5AC expression in gall bladder lesions. J Clin Diagn
Res. 11:EC12–EC16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Barreto SG, Dutt A and Chaudhary A: A
genetic model for gallbladder carcinogenesis and its dissemination.
Ann Oncol. 25:1086–1097. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vilkin A, Nudelman I, Morgenstern S,
Geller A, Bar Dayan Y, Levi Z, Rodionov G, Hardy B, Konikoff F,
Gobbic D and Niv Y: Gallbladder inflammation is associated with
increase in mucin expression and pigmented stone formation. Dig Dis
Sci. 52:1613–1620. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tsuchiya Y, Kiyohara C, Sato T, Nakamura
K, Kimura A and Yamamoto M: Polymorphisms of cytochrome P450 1A1,
glutathione S-transferase class mu, and tumour protein p53 genes
and the risk of developing gallbladder cancer in Japanese. Clin
Biochem. 40:881–886. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mochidome N, Koga Y, Ohishi Y, Miyazaki T,
Matsuda R, Yamada Y, Aishima S, Nakamura M and Oda Y: Prognostic
implications of the coexisting precursor lesion types in invasive
gallbladder cancer. Hum Pathol. 114:44–53. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Agrawal V, Goel A, Krishnani N, Pandey R,
Agrawal S and Kapoor VK: p53, carcinoembryonic antigen and
carbohydrate antigen 19.9 expression in gall bladder cancer,
precursor epithelial lesions and xanthogranulomatous cholecystitis.
J Postgrad Med. 56:262–266. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rao RV, Kumar A, Sikora SS, Saxena R and
Kapoor VK: Xanthogranulomatous cholecystitis: Differentiation from
associated gall bladder carcinoma. Trop Gastroenterol. 26:31–33.
2005.PubMed/NCBI
|
|
8
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lazcano-Ponce EC, Miquel JF, Muñoz N,
Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Duffy A, Capanu M, Abou-Alfa GK, Huitzil
D, Jarnagin W, Fong Y, D'Angelica M, Dematteo RP, Blumgart L and
O'Reilly EM: Gallbladder cancer (GBC): 10-year experience at
memorial Sloan-kettering cancer centre (MSKCC) J Surg. Oncol.
98:485–489. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Oral O, Unverdi H, Kumcu E, Turkbey D,
Dogan S and Hucumenoglu S: Associations between the expression of
mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic
parameters of human breast carcinomas. Indian J Pathol Microbiol.
63:551–558. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Díaz Del Arco C, Garré P, Molina Roldán E,
Lorca V, Cerón Nieto MÁ and Fernández Aceñero MJ: MUC1 expression
in colorectal carcinoma: Clinicopathological correlation and
prognostic significance. Rev Esp Patol. 51:204–209. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Walsh MD, Clendenning M, Williamson E,
Pearson SA, Walters RJ, Nagler B, Packenas D, Win AK, Hopper JL,
Jenkins MA, et al: Expression of MUC2, MUC5AC, MUC5B, and MUC6
mucins in colorectal cancers and their association with the CpG
island methylator phenotype. Mod Pathol. 26:1642–1656.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hazgui M, Weslati M, Boughriba R, Ounissi
D, Bacha D and Bouraoui S: MUC1 and MUC5AC implication in Tunisian
colorectal cancer patients. Turk J Med Sci. 51:309–318.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yoo KS, Choi HS, Jun DW, Lee HL, Lee OY,
Yoon BC, Lee KG, Paik SS, Kim YS and Lee J: MUC expression in
gallbladder epithelial tissues in cholesterol-associated
gallbladder disease. Gut Liver. 10:851–858. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Xiong L, Yang Z, Yang L, Liu J and Miao X:
Expressive levels of MUC1 and MUC5AC and their clinicopathologic
significances in the benign and malignant lesions of gallbladder. J
Surg Oncol. 105:97–103. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ghosh M, Kamma H, Kawamoto T, Koike N,
Miwa M, Kapoor VK, Kapoor VK, Krishnani N, Agrawal S, Ohkohchi N
and Todoroki T: MUC 1 core protein as a marker of gallbladder
malignancy. Eur J Surg Oncol. 31:891–896. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lau SK, Weiss LM and Chu PG: Differential
expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites
an immunohistochemical study. Am J Clin Pathol. 122:61–69.
2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Laitio M: Histogenesis of epithelial
neoplasms of human gallbladder I. Dysplasia. Pathol Res Pract.
178:51–56. 1983.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Albores-Saavedra J, Alcantra-Vazquez A,
Cruz-Ortiz H and Herrera-Goepfert R: The precursor lesions of
invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia
and carcinoma in situ. Cancer. 45:919–927. 1980.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Roa I, Villaseca M, Araya J, Roa J,
Aretxabala X, Melo A and Ibacache G: p53 tumor suppressor gene
protein expression in early and advanced gallbladder carcinoma.
Histopathology. 31:226–230. 1997.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nakajo S, Yamamoto M and Tahara E:
Morphometrical analysis of gall-bladder adenoma and adenocarcinoma
with reference to histogenesis and adenoma-carcinoma sequence.
Virchows Arch A Pathol Anat Histopathol. 417:49–56. 1990.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hidalgo Grau LA, Badia JM, Salvador CA,
Monsó TS, Canaleta JF, Nogués JM and Sala JS: Gallbladder
carcinoma: The role of p53 protein overexpression and Ki-67 antigen
expression as prognostic markers. HPB (Oxford). 6:174–180.
2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sasatomi E, Tokunaga O and Miyazaki K:
Precancerous conditions of gallbladder carcinoma: Overview of
histopathologic characteristics and molecular genetic findings. J
Hepatobiliary Pancreat Surg. 7:556–5567. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wistuba I, Gazdar A, Roa I and
Albores-Saavedra J: p53 protein overexpression in gallbladder
carcinoma and its precursor lesions: An immunohistochemical study.
Hum Pathol. 27:360–365. 1996.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Misra S, Chaturvedi A, Goel M, Mehrotra R,
Sharma ID, Srivastava AN and Misra NC: Overexpression of p53
protein in gallbladder carcinoma in North India. Eur J Surg Oncol.
26:164–167. 2000.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sharma A, Sharma KL, Gupta A, Yadav A and
Kumar A: Gallbladder cancer epidemiology, pathogenesis and
molecular genetics: Recent update. World J Gastroenterol.
23:3978–3998. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jain K, Sreenivas V, Velpandian T, Kapil U
and Garg PK: Risk factors for gallbladder cancer: A case-control
study. Int J Cancer. 132:1660–1666. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lichtenstein P, Holm NV, Verkasalo PK,
Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki
K: Environmental and heritable factors in the causation of
cancer-analyses of cohorts of twins from Sweden, Denmark, and
Finland. N Engl J Med. 343:78–85. 2000.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kumar N, Rajput D, Gupta A, Popuri V,
Kundal A, Sharma J, Puliyath N and Shasheendran S: Utility of
triple tumor markers CA19-9, CA125 and CEA in predicting advanced
stage of carcinoma gallbladder: A retrospective study. Int Surg J.
7:2527–2531. 2020.
|
|
31
|
Zhang Y, Yang J, Li H, Wu Y, Zhang H and
Chen W: Tumor markers CA19-9, CA242 and CEA in the diagnosis of
pancreatic cancer: A meta-analysis. Int J Clin Exp Med.
8:11683–11691. 2015.PubMed/NCBI
|
|
32
|
Grunnet M and Mau-Sørensen M: Serum tumor
markers in bile duct cancer: A review. Biomarkers. 19:437–443.
2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Grigoriu ME, Costea RV, Grigoriu CI and
Furtunescu FL: Endoscopic management of choledocolithiasis related
to periampullary duodenal diverticula. Med Surg J. 122:102–108.
2018.
|
|
34
|
Shukla VK, Gurubachan Sharma D, Dixit VK
and Usha : Diagnostic value of serum CA242, CA 19-9, CA 15-3
and CA 125 in patients with carcinoma of the gallbladder. Trop
Gastroenterol. 27:160–165. 2006.PubMed/NCBI
|
|
35
|
Chaube A, Tewari M, Singh U and Shukla HS:
CA 125: A potential tumor marker for gallbladder cancer. J Surg
Oncol. 93:665–669. 2006.PubMed/NCBI View Article : Google Scholar
|
